abstract |
The present invention relates to a compound of formula (I) wherein Q, A 1 -A 8 , R 4 and R 5 are as described herein. The compounds of formula (I) and pharmaceutical compositions thereof are useful for the treatment of diseases and disorders in which undesirable or excessive activation of NF-kB signaling is observed. |